DECISION OF THE EEA JOINT COMMITTEE No 312/2022

of 9 December 2022

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/1254]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2021/2049 of 24 November 2021 renewing the approval of the active substance cypermethrin as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Regulation (EU) 2021/2068 of 25 November 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Regulation (EU) 2021/2081 of 26 November 2021 concerning the non-renewal of approval of the active substance indoxacarb, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 ( 3 ) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Regulation (EU) 2022/4 of 4 January 2022 approving the active substance Purpureocillium lilacinum strain PL11 as a low-risk substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 ( 4 ) is to be incorporated into the EEA Agreement.

(5) Commission Implementing Regulation (EU) 2022/19 of 7 January 2022 renewing the approval of the active substance Purpureocillium lilacinum strain 251 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 ( 5 ) is to be incorporated into the EEA Agreement.

(6) Commission Implementing Regulation (EU) 2022/43 of 13 January 2022 renewing the approval of the active substance flumioxazin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annexes to Commission Implementing Regulation (EU) No 540/2011 and to Implementing Regulation (EU) 2015/408 ( 6 ) is to be incorporated into the EEA Agreement.

(7) Commission Implementing Regulation (EU) 2022/159 of 4 February 2022 approving the low-risk active substance Bacillus amyloliquefaciens strain IT-45 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 ( 7 ) is to be incorporated into the EEA Agreement.

(8) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Chapter XV of Annex II to the EEA Agreement shall be amended as follows:

The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):

‘–

32021 R 2049 : Commission Implementing Regulation (EU) 2021/2049 of 24 November 2021 ( OJ L 420, 25.11.2021, p. 6 ),

–

32021 R 2068 : Commission Implementing Regulation (EU) 2021/2068 of 25 November 2021 ( OJ L 421, 26.11.2021, p. 25 ),

–

32021 R 2081 : Commission Implementing Regulation (EU) 2021/2081 of 26 November 2021 ( OJ L 426, 29.11.2021, p. 28 ),

–

32022 R 0004 : Commission Implementing Regulation (EU) 2022/4 of 4 January 2022 ( OJ L 1, 5.1.2022, p. 5 ),

–

32022 R 0019 : Commission Implementing Regulation (EU) 2022/19 of 7 January 2022 ( OJ L 5, 10.1.2022, p. 9 ),

–

32022 R 0043 : Commission Implementing Regulation (EU) 2022/43 of 13 January 2022 ( OJ L 9, 14.1.2022, p. 7 ),

–

32022 R 0159 : Commission Implementing Regulation (EU) 2022/159 of 4 February 2022 ( OJ L 26, 7.2.2022, p. 7 ).’

The following indent is added in point 13zzzzt (Commission Implementing Regulation (EU) 2015/408):

‘-

32022 R 0043 : Commission Implementing Regulation (EU) 2022/43 of 13 January 2022 ( OJ L 9, 14.1.2022, p. 7 ).’

The following points are inserted after point 13zzzzzzzzzzzzf (Commission Implementing Regulation (EU) 2021/1451):

‘13zzzzzzzzzzzzg.

32021 R 2049 : Commission Implementing Regulation (EU) 2021/2049 of 24 November 2021 renewing the approval of the active substance cypermethrin as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 ( OJ L 420, 25.11.2021, p. 6 ).

13zzzzzzzzzzzzh.

32021 R 2081 : Commission Implementing Regulation (EU) 2021/2081 of 26 November 2021 concerning the non-renewal of approval of the active substance indoxacarb, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L 426, 29.11.2021, p. 28 ).

13zzzzzzzzzzzzi.

32022 R 0004 : Commission Implementing Regulation (EU) 2022/4 of 4 January 2022 approving the active substance Purpureocillium lilacinum strain PL11 as a low-risk substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L 1, 5.1.2022, p. 5 ).

13zzzzzzzzzzzzj.

32022 R 0019 : Commission Implementing Regulation (EU) 2022/19 of 7 January 2022 renewing the approval of the active substance Purpureocillium lilacinum strain 251 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 ( OJ L 5, 10.1.2022, p. 9 ).

13zzzzzzzzzzzzk.

32022 R 0043 : Commission Implementing Regulation (EU) 2022/43 of 13 January 2022 renewing the approval of the active substance flumioxazin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annexes to Commission Implementing Regulation (EU) No 540/2011 and to Implementing Regulation (EU) 2015/408 ( OJ L 9, 14.1.2022, p. 7 ).

13zzzzzzzzzzzzl.

32022 R 0159 : Commission Implementing Regulation (EU) 2022/159 of 4 February 2022 approving the low-risk active substance Bacillus amyloliquefaciens strain IT-45 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L 26, 7.2.2022, p. 7 ).’

Article 2

The texts of Implementing Regulations (EU) 2021/2049, (EU) 2021/2068, (EU) 2021/2081, (EU) 2022/4, (EU) 2022/19, (EU) 2022/43 and (EU) 2022/159 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 10 December 2022, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 9 December 2022.

For the EEA Joint Committee

The President

Kristján Andri STEFÁNSSON

( 1 ) OJ L 420, 25.11.2021, p. 6 .

( 2 ) OJ L 421, 26.11.2021, p. 25 .

( 3 ) OJ L 426, 29.11.2021, p. 28 .

( 4 ) OJ L 1, 5.1.2022, p. 5 .

( 5 ) OJ L 5, 10.1.2022, p. 9 .

( 6 ) OJ L 9, 14.1.2022, p. 7 .

( 7 ) OJ L 26, 7.2.2022, p. 7 .

( *1 ) No constitutional requirements indicated.